News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Truscreen Update – Europe And Other Markets

Truscreen Update – Europe And Other Markets

TruScreen enters into distribution agreements for Europe, Central Asia and Middle East

Cervical cancer technology company, TruScreen Limited (NZAX: TRU), the manufacturer of real time cervical cancer screening technology, advises that it has entered into distribution agreements for the sale of its TruScreen device in multiple new markets. These agreements cover territories with a total screening population of 61 million women, and are regions with a historical lack of quality cervical screening programs or with local screening practices that vary considerably in quality.

Europe: TruScreen has recently entered into agreements for distribution of its product into ten (10) European countries including Serbia, Croatia, Macedonia, Montenegro, Kosovo, Bosnia and Slovenia, Germany, Austria and Switzerland. These agreements cover a target screening population of approximately 34 million women, ranging from countries with very poor access to health resources to those with very well developed health resources.

Central Asia: Following a recent visit to TruScreen by a delegation from Kazakhstan, which included representatives of the Ministry of Health and Social Development of the Kazakhstan Government, TruScreen has entered into an agreement for the distribution of the TruScreen device in the region. Kazakhstan has approximately 5 million women of screening age.

Middle East: TruScreen has also recently entered into an agreement for the distribution of TruScreen in Iran. Iran has the largest population in the Middle East, with approximately 22 million women of screening age.

CEO of TruScreen, Marty Dillon, said: “The launch of our second generation device, Truscreen2, has further strengthened our proposition and we are now actively focused on building awareness and sales of our technology into new territories. The execution of these distribution agreements announced today, significantly enhances the potential for sales growth in Europe and other markets.

“It is evident from all our discussions that there is a great need and desire for an objective screening technology such as TruScreen, which can operate in developing countries outside the traditional laboratory infrastructure.”

TruScreen’s partners in these territories include Kebomed Europe AG, which has eight offices across Northern and Western Europe.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines

Repatriation: Moriori And Māori Ancestors Offered Dignity And Respect

The Museum of New Zealand Te Papa Tongarewa will hold a pōwhiri to mark the return home of 59 Māori and Moriori ancestral remains from the United Kingdom and Europe. More>>

Gibbs Farm: Kiwi Sculpture Park Rated As Site Of International Stature

29 May 2017 – The Wall Street Journal has honoured internationally renowned art patron and entrepreneur Alan Gibbs with a multi-page feature spread about his sculpture park at the Gibbs Farm, north of Auckland, in the June Issue of WSJ Magazine. More>>


Wellington Rugby Zeroes: Sevens To Move To Hamilton

Wellington Mayor Justin Lester: “The Sevens has been a big part of recent Wellington history but it was time for the event to move on… Wellingtonians have been voting with their feet in the last few years and we’ve seen the result in dwindling crowd numbers and lower ticket sales.” More>>


Matafeo & Dravid: The Billy T And Fred Award Winners For 2017

At the final show of the 2017 NZ International Comedy Festival powered by Flick Electric Co. the Festival came to a close after 115 shows in Auckland and 68 shows in Wellington. More>>



  • Wellington
  • Christchurch
  • Auckland